跳至主要内容
临床试验/IRCT20150721023282N25
IRCT20150721023282N25尚未招募3 期

Evaluation of the effectiveness of curcumin in improving the symptoms of patients with chronic coronary syndrome: a randomized double-blind placebo-controlled clinical trial

Esfahan University of Medical Sciences0 个研究点目标入组 44 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Age above 18 years
  • Suffering from chronic coronary syndrome according to the guidelines of the European Society of Cardiology (ESC) published in 2019
  • Full consent to participate in the study

排除标准

  • Using any product containing curcumin and turmeric during the last weekcontent_copyshare
  • History of acute coronary syndrome in the last 6 months
  • Suffering from any other heart disorders including myocarditis, cardiomyopathy and severe valvular disorder
  • Having hyperthyroidism
  • Having kidney failure (creatinine clearance less than 60 ml/min)
  • Liver disorder (Child-pugh score stage B or C)
  • Using psychoactive drugs (alcohol, marijuana, opioids, cocaine, dextroamphetamine)
  • The use of any anti-inflammatory or antioxidant drug (corticosteroid, NSAID, vitamins C or E, coenzyme Q10 products, immunosuppressive drugs, ...) from one week before the start of the intervention
  • Suffering from other cognitive disorders
  • History of allergy to curcumin
  • Difficulty hearing or speaking
  • breastfeeding

研究者

相似试验